- Residency and Fellowship Programs
- Advanced Radiation Oncology Fellowship
- Advanced Therapeutic Endoscopy Fellowship
- Blood Banking/Transfusion Medicine Fellowship
- Body Imaging Fellowship
- Breast Imaging Fellowship
- Breast Surgical Oncology Fellowship
- Cancer Anesthesia Residency/Fellowship
- Cancer Rehabilitation Fellowship
- Chemical Pathology Fellowship
- Complex General Surgical Oncology Fellowship
- Cytopathology Fellowship
- Procedural Dermatology Fellowship
- Dermatopathology Fellowship
- Felix Rutledge Fellowship in Gynecologic Oncology
- Gynecologic Oncology Fellowship
- Head and Neck Surgical Oncology and Reconstruction Fellowship
- Hematology/Oncology Fellowship Program
- Hematopathology Fellowship
- Hospice and Palliative Medicine Fellowships
- Internal Medicine Residency Program
- Interventional Radiology Integrated Residency
- Investigational Cancer Therapeutics Fellowship
- Leukemia Fellowship
- Lymphoma/Myeloma Fellowship
- Microvascular Reconstructive Surgery
- Molecular Genetic Pathology Fellowship
- Musculoskeletal Oncology Fellowship
- Musculoskeletal Radiology Fellowship
- Neuro-Oncology Fellowship
- Neurosurgical Oncology Fellowship
- Oncologic Emergency Medicine Fellowship
- Oncologic Endocrinology Fellowship
- Onco-nephrology Fellowship
- Oncologic Neuroradiology
- Ophthalmic Plastic and Reconstructive Surgery Fellowship (ASOPRS /ACGME)
- Oral Oncology & Maxillofacial Prosthetics
- Pain Medicine Fellowship
- Pediatric Hematology & Oncology Fellowship
- Radiation Oncology Residency
- Selective Breast Pathology Fellowship
- Selective Cancer Biomarker Pathology Fellowship
- Selective Gastrointestinal & Liver Pathology Fellowship
- Selective Genitourinary Pathology Fellowship
- Selective Gynecologic Pathology Fellowship
- Selective Head & Neck Pathology Fellowship
- Selective Soft Tissue Pathology Fellowship
- Selective Surgical Pathology Fellowship
- Selective Thoracic Pathology Fellowship
- Stem Cell Transplantation and Cellular Therapy
- Surgical Endocrinology Fellowship
- Thoracic Head & Neck Medical Oncology Fellowship
- Thoracic Radiology Fellowship
- Thoracic Surgery Fellowship
- Urinary Tract and Pelvic Reconstruction Fellowship
- Urologic Oncology Fellowship
- Vascular & Interventional Radiology Fellowship
Investigational Cancer Therapeutics Fellowship
The Investigational Cancer Therapeutics Fellowship provides an exemplary training experience for fellows who wish to become experts in personalized cancer therapies and novel drug development, and prepare fellows for careers as the next generation of independent clinical researchers.
The fellowship offers a one-, two-, or three-year experience in early drug development. Fellows are trained in developing and conducting innovative clinical/translational trials with novel, targeted agents and are prepared for careers in academics, the pharmaceutical industry or government.
MD Anderson provides a rich experience for fellows. Over 120,000 patients were seen here last year, and nearly one-third were new patients. Almost 7,600 participants were enrolled in clinical trials exploring innovative treatments. In FY2013, our department alone had over 122 therapeutic trials and enrolled over 1,000 patients on our protocols. About one-fourth of our phase I trials are first-in-human studies.
There is a wealth of opportunity for interactions with a wide variety of investigators who are internationally known for their expertise in basic, translational and/or clinical science. Fellows will learn how to write trials, interact with sponsors, develop translational endpoints to understand drug impact and factors predicting response and host toxicity, present data at national or international meetings, analyze data and write/complete manuscripts.
Eligibility
Program applicants should have:
- M.D. or D.O. degree
- Completed an hematology/oncology residency or equivalent training
- An interest in a career in drug development
- Passed the licensure exam (USMLE Steps 1 & 2)
- Foreign-trained applicants must have ECFMG certification
Although completion of medical oncology training is not a requirement, fellows who have completed this training will be highly competitive for a fellowship position.
The Fellowship is supported by the Jeanne F. Shelby Scholarship Fund for Investigational Cancer Therapeutics.
Conferences & Courses
Weekly Meetings
- Investigational Cancer Therapeutics Grand Rounds
- Clinical Trials Treatment Planning Meeting
- Journal Club
Fall Courses
- Ethics in Clinical Trials Research (GS21 1102)
- Translational Sciences: From Bedside to Bench and Back (GS21 1232)
- Seminars in Clinical Cancer Research (GS21 1011)
- Seminars in Clinical Cancer Treatment (GS21 1031)
Spring Courses
- Human Protocol Research (GS21 1132)
- Translational Cancer Research (GS21 1613)
Summer Course
- Resources and Methods for Analysis of Patient-Derived Samples (GS21 1121)
Contact Us
Mary Nowak
Administrative Assistant to:
Sarina Piha-Paul, M.D.
Department of Investigational Cancer Therapeutics
1515 Holcombe Blvd, Unit 455
Houston, TX 77030
Phone: 713-563-1055
Fax: 713-792-3535
Related Resources
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.